Teacher Retirement System of Texas Sells 56,422 Shares of Avanos Medical, Inc. (NYSE:AVNS)

Teacher Retirement System of Texas lowered its stake in Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 47.3% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 62,871 shares of the company's stock after selling 56,422 shares during the quarter. Teacher Retirement System of Texas owned 0.14% of Avanos Medical worth $1,001,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of the stock. Intech Investment Management LLC increased its stake in Avanos Medical by 467.5% in the fourth quarter. Intech Investment Management LLC now owns 48,782 shares of the company's stock valued at $777,000 after purchasing an additional 40,186 shares in the last quarter. William Blair Investment Management LLC increased its position in Avanos Medical by 2.1% in the 4th quarter. William Blair Investment Management LLC now owns 1,406,210 shares of the company's stock valued at $22,387,000 after buying an additional 28,608 shares in the last quarter. Natixis Advisors LLC raised its stake in Avanos Medical by 20.9% during the 4th quarter. Natixis Advisors LLC now owns 25,944 shares of the company's stock worth $413,000 after buying an additional 4,492 shares during the period. Amundi boosted its holdings in Avanos Medical by 200.4% in the fourth quarter. Amundi now owns 23,024 shares of the company's stock worth $355,000 after acquiring an additional 15,359 shares in the last quarter. Finally, US Bancorp DE grew its stake in Avanos Medical by 18.0% in the fourth quarter. US Bancorp DE now owns 14,093 shares of the company's stock valued at $224,000 after acquiring an additional 2,147 shares during the period. Institutional investors and hedge funds own 95.17% of the company's stock.

Insider Activity

In related news, SVP Kerr Holbrook sold 7,000 shares of the stock in a transaction on Thursday, March 6th. The stock was sold at an average price of $15.25, for a total value of $106,750.00. Following the completion of the sale, the senior vice president now directly owns 82,047 shares of the company's stock, valued at approximately $1,251,216.75. This represents a 7.86 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 2.64% of the company's stock.

Avanos Medical Stock Up 1.0 %

Shares of Avanos Medical stock traded up $0.15 during trading hours on Wednesday, reaching $14.50. The company's stock had a trading volume of 550,940 shares, compared to its average volume of 314,131. The company has a market capitalization of $667.04 million, a P/E ratio of 42.65 and a beta of 1.17. The stock's fifty day simple moving average is $15.56 and its two-hundred day simple moving average is $18.15. Avanos Medical, Inc. has a one year low of $13.87 and a one year high of $25.36. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.46 and a current ratio of 2.22.

Avanos Medical (NYSE:AVNS - Get Free Report) last announced its quarterly earnings results on Wednesday, February 26th. The company reported $0.43 earnings per share for the quarter, beating the consensus estimate of $0.40 by $0.03. The business had revenue of $179.60 million for the quarter, compared to analysts' expectations of $177.23 million. Avanos Medical had a net margin of 2.30% and a return on equity of 4.70%. On average, research analysts forecast that Avanos Medical, Inc. will post 1.32 earnings per share for the current year.

Analyst Upgrades and Downgrades

Separately, StockNews.com raised Avanos Medical from a "hold" rating to a "buy" rating in a research report on Wednesday, March 19th.

Avanos Medical Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.